Hughes Steven George 4
4 · Avidity Biosciences, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-15$6.57/sh+1,542$10,131→ 40,409 total - Sale
Common Stock
2025-09-15$45.41/sh−1,542$70,022→ 38,867 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-15−1,542→ 49,333 totalExercise: $6.57Exp: 2033-09-10→ Common Stock (1,542 underlying)
Footnotes (2)
- [F1]The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of September 11, 2023 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the option shall be fully vested on the fourth anniversary of the Vesting Commencement Date.